26.07
-0.44(-1.66%)
Currency In USD
| Previous Close | 26.51 |
| Open | 26.53 |
| Day High | 26.75 |
| Day Low | 25.93 |
| 52-Week High | 27.64 |
| 52-Week Low | 13.79 |
| Volume | 494,790 |
| Average Volume | 657,003 |
| Market Cap | 1.17B |
| PE | -9.48 |
| EPS | -2.75 |
| Moving Average 50 Days | 24.38 |
| Moving Average 200 Days | 23.83 |
| Change | -0.44 |
If you invested $1000 in Pacira BioSciences, Inc. (PCRX) 10 years ago, it would be worth $390.68 as of September 18, 2025 at a share price of $26.07. Whereas If you bought $1000 worth of Pacira BioSciences, Inc. (PCRX) shares 5 years ago, it would be worth $428.99 as of September 18, 2025 at a share price of $26.07.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
GlobeNewswire Inc.
Jul 24, 2025 12:00 PM GMT
BRISBANE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will rep
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
GlobeNewswire Inc.
Jul 22, 2025 12:00 PM GMT
Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access BRISBANE, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery o
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
GlobeNewswire Inc.
Jun 18, 2025 12:00 PM GMT
- Produced for Pacira by BBC StoryWorks Commercial Productions, The Next Frontier: Mark & Leah’s Story Highlights the Impact of Non-Opioid Solutions - BRISBANE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the